CLOVER HEALTH INVESTMENTS, CORP. /DE Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic of $3.26 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic · last filed 2025-03-03
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-12-31 was -$611.00K.
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-09-30 was -$370.00K.
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-06-30 was $238.00K, a 217.33% increase year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-03-31 was $4.00M, a 43.60% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2024 was $3.26M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2023 was -$3.21M.
- CLOVER HEALTH INVESTMENTS, CORP. /DE net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2022 was -$84.98M.
| Period end | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 3 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 6 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 9 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$981.00K derived: sum of 2 quarters · filed 2025-03-03 | -$743.00K derived: sum of 3 quarters · filed 2025-03-03 | $3.26M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$370.00K 10-Q · filed 2024-11-08 | -$132.00K derived: sum of 2 quarters · filed 2024-11-08 | $3.87M 10-Q · filed 2024-11-08 | $1.34M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | $238.00K 10-Q · filed 2024-08-08 | $4.24M 10-Q · filed 2024-08-08 | $1.71M derived: sum of 3 quarters · filed 2025-03-03 | -$6.14M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | $4.00M 10-Q · filed 2024-05-07 | $1.47M derived: sum of 2 quarters · filed 2025-03-03 | -$6.38M derived: sum of 3 quarters · filed 2025-03-03 | -$6.30M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | -$2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$10.38M derived: sum of 2 quarters · filed 2025-03-03 | -$10.30M derived: sum of 3 quarters · filed 2025-03-03 | -$3.21M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$7.85M 10-Q · filed 2024-11-08 | -$7.78M derived: sum of 2 quarters · filed 2024-11-08 | -$686.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $75.00K 10-Q · filed 2024-08-08 | $7.17M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $7.09M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$84.98M 10-K · filed 2025-03-03 |